Search the Newsreel

Bausch Health (TSX:BHC) Moves Higher After Annual Guidance Upgrade

Bausch Health Companies (TSX:BHC) Gains Investor Attention as Recovery Momentum Builds Across Healthcare Portfolio

Anheuser-Busch InBev tops Brewers with 13.6M-share move to the edge of its high

BUD gained 5.9% for the week and closed just 0.1% below its 52-week high, but the stronger price action comes with a rich fair-value gap and a thinner activity-pressure read.

Bausch Health Companies Inc. (BHC) Stock Analysis: Uncovering A 7.14% Upside Potential

Bausch Health Companies Inc. (BHC) is a healthcare company with a diversified portfolio showing a potential upside of 7.14%. Despite mixed valuation metrics and cautious analyst ratings, the company boasts solid revenue growth and substantial free cash flow. Investors are advised to monitor technical …

H.C. Wainwright raises Bausch & Lomb stock price target to $21

H.C. Wainwright has increased its price target for Bausch & Lomb Corp. (NYSE:BLCO) to $21 from $20, maintaining a Buy rating after the company reported strong second-quarter 2026 financial results. Bausch & Lomb exceeded revenue projections with $1,394 million and saw growth across all …

Bausch + Lomb Introduces New Eyecare Professional Hub

Bausch + Lomb has launched a new Eyecare Professional Hub, centralizing scientific publications, clinical evidence, educational resources, and upcoming events for eyecare professionals. This platform aims to simplify access to critical information, supporting ECPs in their practice and patient care. The hub provides details …

Brokers Offer Predictions for Bausch + Lomb Q1 Earnings

NuScale Power (SMR) Heads Into Earnings With Project Updates Putting Valuation Back In Focus

TruScreen Group Limited Quotes 50,000 Ordinary Shares Following Option Exercise

TruScreen Group Limited Applies to Quote 40,878,570 New Ordinary Shares

Did Bausch + Lomb’s Stronger Q2 and Higher 2026 Revenue Guidance Just Shift BLCO’s Investment Narrative?

Bausch Health Companies Stock: 5 Straight Green Days, Up 56%

Bausch Health Companies (BHC) stock has seen a significant surge, climbing 56% over five consecutive trading days and adding $923 million to its market value. While this streak shows strong near-term momentum and attention from the market, investors are encouraged to re-evaluate the underlying …

The Manufacturers Life Insurance Company Trims Stake in Anheuser-Busch InBev SA/NV $BUD

The Manufacturers Life Insurance Company reduced its stake in Anheuser-Busch InBev SA/NV by 29.2% in the first quarter, selling 71,090 shares and retaining 172,353 shares worth $11.96 million. Despite this, AB InBev reported better-than-expected quarterly results with an 11% year

Price to earnings forward of NuScale Power Corporation Class A – BX:SMR

This article provides financial information for NuScale Power Corporation Class A, traded under the symbol SMR on the BX Swiss exchange. It focuses on the company's price to earnings forward metric within the financial overview. The data and intellectual property are provided by various …

H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $21

H.C. Wainwright has reiterated its Buy rating for Bausch + Lomb Corp. (BLCO.US) and increased the price target to $21. This indicates a positive outlook from the analyst firm regarding the company's future stock performance.

Here's How to Play NuScale Stock Before Q2 Earnings Release

NuScale Power Corporation SMR is slated to release second-quarter 2026 results on Aug. 5, after market close. The Zacks Consensus Estimate for revenues is pegged at $1 million, implying a decrease of 87.6% from the year-ago quarter. The consensus mark of -$0.13 per share …

Quantinno Capital Management LP Buys 48,223 Shares of Anheuser-Busch InBev SA/NV $BUD

Quantinno Capital Management LP significantly increased its stake in Anheuser-Busch InBev SA/NV (BUD) during the first quarter, purchasing 48,223 additional shares, bringing their total holdings to $14.9 million. This comes as AB InBev reported stronger-than-expected second-quarter results, with EPS and revenue surpassing analyst consensus …

Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Its 9.65% Potential Upside

Bausch + Lomb Corporation (BLCO), an eye health leader with a $6.04 billion market cap, shows a 9.65% potential upside despite a negative EPS and ROI. The company's robust revenue growth of 9.10% across its Vision Care, Pharmaceuticals, and Surgical segments, along with a …

NuScale Power (NYSE: SMR) Earnings Report Could Reverse A 50% Stock Decline

NuScale Power Corporation (SMR) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. The report details the financial condition and results of operations, highlighting a significant increase in outstanding Class A shares due to a completed at-the-market program …

AB InBev investor E.P.S. seeks to sell 10M shares - report

[Anheuser-Busch Facility] Trevor Srednick/iStock Editorial via Getty Images * Budweiser maker Anheuser-Busch InBev (BUD [https://seekingalpha.com/symbol/BUD]) shareholder E.P.S. SA, a holding company, is selling about 10M shares in the Belgian brewer through a placement managed by JPMorgan Securities, _Reuters_ repported. * Based on Anheuser-Busch InBev's …

E.P.S. to Sell 10 Million AB InBev Shares Worth €752 Million

E.P.S. SA, a significant shareholder in Anheuser-Busch InBev, is selling approximately 10 million shares in the brewing company. This share placement is being managed by JPMorgan Securities and is estimated to be worth around €752 million ($867.21 million). E.P.S. currently holds over 67 million …

Budweiser Maker AB InBev Credits FIFA World Cup for Volume Lift, Sees Bigger Payoff Ahead

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Anheuser-Busch InBev SA stock edged higher Thursday after the brewer reported second-quarter results that beat analyst expectations, supported by organic revenue growth, higher beer volumes, and stronger …

Is Anheuser-Busch InBev (ENXTBR:ABI) Undervalued As Earnings And Dividend Support Its Rally?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Anheuser-Busch InBev (ENXTBR:ABI) is back in focus after reporting half year 2026 earnings, with sales of US$31.9b and net income of US$6.3b, alongside …

BHC Surges As Bausch Health Crushes Q2 And Lifts 2026 Outlook

Bausch Health Companies Inc. (BHC) saw its stock surge by 13.62% after reporting strong Q2 results, crushing consensus estimates for EPS and revenue, and lifting its 2026 outlook. The company demonstrated its 13th consecutive quarter of revenue and adjusted EBITDA growth, driven by strong …

Bausch Health Companies Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:BHC)

Bausch Health Companies Inc. has published its 2026 Q2 earnings call presentation. The company reported an EPS of $1.26, beating estimates by $0.25, and revenue of $2.85 billion, surpassing expectations by $192.90 million with a 12.73% year-over-year increase. This presentation is available for investors …

Is Anheuser-Busch InBev (ENXTBR:ABI) Still Cheap After Strong Q2 Earnings?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Anheuser-Busch InBev stock has delivered a strong 52.4% return over the past year, and the current checks still suggest the shares screen as undervalued rather than fully …

NuScale Power's Next Earnings Report on Aug. 5 Could Send the Stock Soaring. Here's Why.

NuScale Power Corporation (SMR) has filed its quarterly earnings report (Form 10-Q) for the period ended June 30, 2026. The report details the financial condition and results of operations, highlighting a significant increase in outstanding Class A shares due to a completed at-the-market program …

Anheuser-Busch InBev (ENXTBR:ABI) Posts Strong Q2 With Market Share Gains

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. AB InBev reported strong Q2 2026 results with gains in global market share. The …

RBC Capital Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)

RBC Capital analyst Douglas Miehm reiterated a Buy rating on Bausch + Lomb Corporation (BLCO) with a price target of $21.00. This follows a Buy rating from UBS and a Sell rating from Bank of America Securities. The company reported a Q2 revenue of …

BHC Soars As Bausch Health Earnings Beat Triggers Repricing

Bausch Health Companies Inc. (BHC) surged by 13.62% following stronger-than-expected Q2 earnings, beating consensus on both EPS and revenue, marking its 13th consecutive quarter of revenue and adjusted EBITDA growth. The company also reported strong operating cash flow and reduced net debt, leading to …

RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21

RBC Capital has reiterated its Buy rating for Bausch + Lomb Corp. (BLCO.US) and maintained its target price at $21. This indicates continued confidence in the company's performance and future outlook from the investment bank.

AB InBev Files Amended H1 2026 Interim Report with U.S. SEC

Anheuser-Busch InBev (BUD) has filed an amended H1 2026 interim report with the U.S. SEC. This filing updates a previous report to comply with SEC rules on non-GAAP measures and disclosure, without changing the underlying operational results for the six-month period ended June 30, …

Bausch Health Companies Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:BHC) 2026-08-01

Bausch Health Companies Inc. has published its 2026 Q2 earnings call presentation. The company reported an EPS of $1.26, beating estimates by $0.25, and revenue of $2.85 billion, surpassing expectations by $192.90 million with a 12.73% year-over-year increase. This presentation is available for investors …

Anheuser-Busch InBev: Unfavourable Risk-Reward, In My Opinion

Bausch + Lomb Corporation Revenue Breakdown – NYSE:BLCO

NuScale Power (SMR) Gains Fresh SMR Backing, Is A $100 Fair Value Credible?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why NuScale Power Stock Is Back in Focus NuScale Power (SMR) is drawing fresh attention after Tennessee Valley Authority and ENTRA1 Energy outlined plans …